Cosmo N.V. (SWX:COPN)
86.90
-4.60 (-5.03%)
Apr 28, 2026, 5:30 PM CET
Cosmo Revenue
In the year 2025, Cosmo had annual revenue of 104.17M EUR, down -60.95%. Cosmo had revenue of 52.45M in the half year ending December 31, 2025, with 6.79% growth.
Revenue
104.17M EUR
Revenue Growth
-60.95%
P/S Ratio
14.51
Revenue / Employee
321.03K EUR
Employees
325
Market Cap
1.41B CHF
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 104.17M | -162.61M | -60.95% |
| Dec 31, 2024 | 266.79M | 174.01M | 187.55% |
| Dec 31, 2023 | 92.78M | -9.31M | -9.12% |
| Dec 31, 2022 | 102.09M | 37.02M | 56.88% |
| Dec 31, 2021 | 65.07M | 4.13M | 6.77% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 63.36B |
| Novartis AG | 44.94B |
| Galderma Group AG | 4.16B |
| Lonza Group AG | 6.53B |
| Tecan Group AG | 882.48M |
| PolyPeptide Group AG | 362.47M |
| Aevis Victoria | 1.04B |
| SKAN Group AG | 333.34M |
Cosmo News
- 7 weeks ago - Cosmo Earnings Call Transcript: H2 2025 - Transcripts
- 9 months ago - Cosmo Earnings Call Transcript: H1 2025 - Transcripts
- 10 months ago - Cosmo Transcript: Investor Day 2025 - Transcripts
- 1 year ago - Cosmo Earnings Call Transcript: H2 2024 - Transcripts
- 1 year ago - Cosmo Earnings Call Transcript: H1 2024 - Transcripts
- 2 years ago - Cosmo Earnings Call Transcript: H2 2023 - Transcripts
- 2 years ago - Cosmo Earnings Call Transcript: H1 2023 - Transcripts
- 3 years ago - Cosmo Earnings Call Transcript: H2 2022 - Transcripts